Stay updated on CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T03:11:23.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site revision as v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-04T00:41:39.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the site revision label advances from v3.7.1 to v3.7.2.
    Difference
    0.8%
    Check dated 2026-10-21T00:43:05.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-07T00:43:32.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Added a new Revision: v3.7.0 entry to the history and removed the previous Revision: v3.6.6 entry, reflecting an update to the study record's version history.
    Difference
    0.1%
    Check dated 2026-09-16T00:10:52.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the record history, replacing the previous v3.6.5, signaling a minor site release update.
    Difference
    0.1%
    Check dated 2026-09-01T19:33:54.000Z thumbnail image

Stay in the know with updates to CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page.